Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results
Lucid (LCID) Prnewswire·2024-08-12 12:07EsoGuard® test volume increased 31 percent quarterly; 44 percent annually Clinical data now well-positioned for final push towards broad coverage and reimbursement Over 50 high-volume #CheckYourFoodTube Precancer Testing Events in 2Q24, including first with upfront contracted payment Conference call and webcast to be held today, August 12th at 8:30 AM EDT NEW YORK, Aug. 12, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical dia ...